Methods in pharmacoepidemiology : Four Studies, four Settings
暂无分享,去创建一个
[1] P. Sedgwick. Number needed to harm , 2011, BMJ : British Medical Journal.
[2] P. Magin,et al. A cross‐sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] Peter D Watson,et al. Acne, anxiety, depression and suicide in teenagers: A cross‐sectional survey of New Zealand secondary school students , 2006, Journal of paediatrics and child health.
[4] Roxanne Nelson. AIDS treatment enters its 25th year. , 2006, The Lancet. Infectious diseases.
[5] A. Bérard,et al. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? , 2006, European Journal of Clinical Pharmacology.
[6] B. Stricker,et al. Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP) , 2006, Scandinavian journal of gastroenterology.
[7] David Nolan,et al. Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics , 2005, Expert opinion on drug safety.
[8] J. Neaton,et al. Grade 4 Events Are as Important as AIDS Events in the Era of HAART , 2003, Journal of acquired immune deficiency syndromes.
[9] G. Steineck,et al. A Swedish case-control network for studies of drug-induced morbidity – acute pancreatitis , 2002, European Journal of Clinical Pharmacology.
[10] M. Leahy,et al. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia , 2002, European journal of haematology.
[11] D. Wysowski,et al. An analysis of reports of depression and suicide in patients treated with isotretinoin. , 2001, Journal of the American Academy of Dermatology.
[12] R. Stern,et al. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study , 2001, The Lancet.
[13] K. Macrae,et al. The Risk of Liver Damage Associated with Minocycline: A Comparative Study , 2001, Journal of clinical pharmacology.
[14] H. Kremers,et al. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. , 2000, Archives of dermatology.
[15] B. Stricker,et al. The risk of acute pancreatitis associated with acid-suppressing drugs. , 2000, British journal of clinical pharmacology.
[16] S. Evans,et al. High early mortality rate from acute pancreatitis in Scotland, 1984–1995 , 1999, The British journal of surgery.
[17] B. Källén. Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin. , 1999, Teratology.
[18] A. Borgström,et al. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden , 1999, The British journal of surgery.
[19] A. Walker. Confounding by indication. , 1996, Epidemiology.
[20] W. Spitzer,et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study , 1996, BMJ.
[21] S Suissa,et al. THE CASE‐TIME-CONTROL DESIGN , 1995, Epidemiology.
[22] Moride Yola,et al. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. , 1994 .
[23] I. Nordback,et al. Pancreatitis in Finland between 1970 and 1989. , 1993, Gut.
[24] M. Maclure. The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.
[25] K. Woo,et al. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy , 1989, The British journal of clinical practice.
[26] P. Fernhoff,et al. Retinoic acid embryopathy. , 1985, The New England journal of medicine.
[27] R. Williamson,et al. Acute pancreatitis: a lethal disease of increasing incidence. , 1985, Gut.
[28] J. J. Stewart,et al. Depression--a side effect of 13-cis-retinoic acid therapy. , 1983, Journal of the American Academy of Dermatology.
[29] G. M. Mead,et al. DRUG-ASSOCIATED PRIMARY ACUTE PANCREATITIS , 1978, The Lancet.
[30] W. Mcbride,et al. Thalidomide and Congenital Abnormalities , 1961 .
[31] Andrew A. Cashner. Just One More Thing , 2007 .
[32] G. Steineck,et al. Interviewer Variability – Quality Aspects in a Case–Control Study , 2006, European Journal of Epidemiology.
[33] M Maclure,et al. Should we use a case-crossover design? , 2000, Annual review of public health.
[34] S. McGuire. Saquinavir gets accelerated approval. , 1996, Positively aware : the monthly journal of the Test Positive Aware Network.